Hongmei Xu
China International Science and Technology Cooperation(CN)National Clinical Research(US)Bicycle Therapeutics (United Kingdom)(GB)Chuxiong Normal University(CN)Second Affiliated Hospital of Zhejiang University(CN)Children's Hospital of Chongqing Medical University(CN)First Hospital of Qinhuangdao(CN)Xi'an Jiaotong University(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Lung Cancer Treatments and Mutations, Forensic and Genetic Research, Molecular Biology Techniques and Applications
Most-Cited Works
- → SHP-2 Phosphatase Negatively Regulates the TRIF Adaptor Protein-Dependent Type I Interferon and Proinflammatory Cytokine Production(2006)243 cited
- → Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects(2008)137 cited
- → Ethnic differences in drug metabolism and toxicity from chemotherapy(2009)119 cited
- → Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages(2008)101 cited
- → Effects of St John's wort andCYP2C9genotype on the pharmacokinetics and pharmacodynamics of gliclazide(2008)92 cited
- → Heat shock up‐regulates expression of Toll‐like receptor‐2 and Toll‐like receptor‐4 in human monocytes via p38 kinase signal pathway(2005)86 cited